Expertise in
13
conditions

Dr. Roger W. Lidman

Rheumatology
816 Greenbrier Circle, Suite A, 
Chesapeake, VA 
Accepting New Patients
Offers Telehealth
Referral may be required
Before you request
Expertise in
13
conditions
816 Greenbrier Circle, Suite A, 
Chesapeake, VA 

Overview

Roger Lidman is a Rheumatologist practicing medicine in Chesapeake, Virginia.

Dr. Lidman is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Polymyalgia Rheumatica, Rhizomelic Pseudopolyarthritis, Osteoporosis, and Postmenopausal Osteoporosis.

Dr. Lidman is board certified in American Board Of Internal Medicine - Rheumatology and American Board Of Internal Medicine - Internal Medicine. He is actively involved in clinical research, participating in 8 clinical trials. Dr. Lidman is currently accepting new patients.

Specialties

Rheumatology

Licenses

Internal Medicine in VA

Board Certifications

American Board Of Internal Medicine - Rheumatology
American Board Of Internal Medicine - Internal Medicine

Fellowships

Medical University of South Carolina-Plastic Surgery - 1980

Hospital Affiliations

SQCN Provider
Sentara Leigh Hospital
Sentara Norfolk General Hospital
The Outer Banks Hospital, Inc
Sentara Obici Hospital
Sentara Princess Anne Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Commonwealth Care Alliance
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HealthKeepers
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Piedmont
  • HMO
  • POS
Sentara Healthcare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE ASSISTANCE PROGRAM
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
TeamCare
  • OTHER COMMERCIAL
Trustmark
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 16 Less Insurance Carriers -

Locations

Center for Arthritis and Rheumatic Disease
816 Greenbrier Circle, Suite A, Chesapeake, VA 23320

Additional Areas of Focus

Dr. Lidman has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Scleroderma
Osteoporosis

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Vectra InVolved Informed Decision Outcome Study (VIVID): A Prospective Randomized Controlled Trial Evaluating the Effect of Guided Care With Vectra Compared to Treatment as Usual in Patients With Rheumatoid Arthritis
Vectra InVolved Informed Decision Outcome Study (VIVID): A Prospective Randomized Controlled Trial Evaluating the Effect of Guided Care With Vectra Compared to Treatment as Usual in Patients With Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: July 21, 2026
Intervention Type: Diagnostic test
A Randomized, Controlled Pragmatic Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
A Randomized, Controlled Pragmatic Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: July 10, 2026
Intervention Type: Drug
Study Drugs: Baricitinib, TNF Inhibitor
Study Phase: Phase 4
A Multicenter, Open-Label, Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis
A Multicenter, Open-Label, Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: October 12, 2023
Intervention Type: Drug
Study Drugs: Olokizumab, Methotrexate
Study Phase: Phase 3
A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate Therapy
A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate Therapy
Enrollment Status: Completed
Publish Date: September 21, 2023
Intervention Type: Drug
Study Phase: Phase 3
A Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Tumor Necrosis Factor Alpha (TNF-α) Inhibitor Therapy
A Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Tumor Necrosis Factor Alpha (TNF-α) Inhibitor Therapy
Enrollment Status: Completed
Publish Date: September 21, 2023
Intervention Type: Drug
Study Drug: Olokizumab
Study Phase: Phase 3
A Multicenter, Long-Term Extension Study of 104 Weeks, Including a Double-Blind, Placebo-Controlled 40-Week Randomized Withdrawal-Retreatment Period, to Evaluate the Maintenance of Treatment Effect of Ixekizumab (LY2439821) in Patients With Axial Spondyloarthritis
A Multicenter, Long-Term Extension Study of 104 Weeks, Including a Double-Blind, Placebo-Controlled 40-Week Randomized Withdrawal-Retreatment Period, to Evaluate the Maintenance of Treatment Effect of Ixekizumab (LY2439821) in Patients With Axial Spondyloarthritis
Enrollment Status: Completed
Publish Date: June 13, 2022
Intervention Type: Drug
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo- Controlled 16-Week Study Followed by Long-Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in TNFi-Experienced Patients With Radiographic Axial Spondyloarthritis
A Multicenter, Randomized, Double-Blind, Placebo- Controlled 16-Week Study Followed by Long-Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in TNFi-Experienced Patients With Radiographic Axial Spondyloarthritis
Enrollment Status: Completed
Publish Date: June 17, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 6 Less Clinical Trials
Similar Doctors
Expertise in
22
conditions
Expertise in
22
conditions
Referral may be required
Before you request

Mayo Clinic-Rochester

5716 Cleveland St Ste 200, 
Virginia Beach, VA 
 (5.3 miles away)
507-284-2511
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Kenneth Warrington is a Rheumatologist practicing medicine in Virginia Beach, Virginia. Dr. Warrington is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Temporal Arteritis, Giant Cell Arteritis (GCA), Vasculitis, Takayasu Arteritis, and Tissue Biopsy. Dr. Warrington is currently accepting new patients.

Expertise in
18
conditions
Expertise in
18
conditions
Referral may be required
Before you request

Mayo Clinic-Rochester

5716 Cleveland St Ste 200, 
Virginia Beach, VA 
 (5.3 miles away)
507-284-2511
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Eric Matteson is a Rheumatologist practicing medicine in Virginia Beach, Virginia. Dr. Matteson is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Polymyalgia Rheumatica, Rhizomelic Pseudopolyarthritis, Giant Cell Arteritis (GCA), Temporal Arteritis, and Tissue Biopsy. Dr. Matteson is currently accepting new patients.

Expertise in
25
conditions
Expertise in
25
conditions
Referral may be required
Before you request

Mayo Clinic-Rochester

5716 Cleveland St Ste 200, 
Virginia Beach, VA 
 (5.3 miles away)
507-284-2511
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Dr. Floranne Ernste, MD is a Rheumatology Specialist in Rochester, MN and has over 19 years of experience in the medical field. Dr. Ernste has extensive experience in Rheumatologic Muscular Diseases and Osteoporosis & Screening. She graduated from East Tennessee State University/James H Quillen College Of Medicine in 2003. She is affiliated with Mayo Clinic Hospital, Saint Marys Campus. Dr. Ernste is highly rated in 25 conditions, according to our data. Her clinical expertise encompasses Dermatomyositis, Polymyositis, Myositis, Inclusion Body Myositis, and Tissue Biopsy.

Frequently Asked Questions about Dr. Roger W. Lidman

How do I make an appointment with Dr. Roger W. Lidman?

You can book an appointment with Dr. Roger W. Lidman by calling their office at 757-461-3400. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Roger W. Lidman a top-rated expert for Polymyalgia Rheumatica?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Roger W. Lidman is classified as an Distinguished expert for Polymyalgia Rheumatica, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Roger W. Lidman specialize in?

While Dr. Roger W. Lidman is a Rheumatology, they have specific expertise in Polymyalgia Rheumatica, Rhizomelic Pseudopolyarthritis, and Osteoporosis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Rheumatology.

Does Dr. Roger W. Lidman accept my insurance?

Dr. Roger W. Lidman accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 757-461-3400 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Lidman's expertise for a condition
ConditionClose
    View All 11 Advanced Conditions
    View All 28 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile